Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Scalp skin grafts effectively cover lower limb defects with high success and minimal complications.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Short-term side effects of low-dose radioactive iodine therapy are common but temporary.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Targeted cancer therapies often cause serious skin problems that need careful management.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Fibroblasts are crucial in scar formation and wound healing, with potential therapies aiming for scarless healing.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Lower SMAD2/3 activation predicts more severe skin cancer.

Complete removal of scalp tumors is crucial, but malignant cases may recur or metastasize, requiring a multidisciplinary approach and close follow-up.

Common skin conditions can greatly affect a person's mental health and social life.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Adult female acne is complex and requires a combination of treatments for effective management.